Today, we gathered 10 selected listings from our investor database. Our team reviewed, checked, and enriched the list with the necessary data.

Here goes:

• 3B Future Health Fund — Monaco, Bayern, Germany-based venture capital fund focused on early-stage healthcare investments, particularly in oncology and rare disease therapeutics. The firm backs start-ups across Europe, the US and Israel, typically at Series A round stage, supporting companies with potential first-in-class assets, strong management teams and revolutionary scientific insights addressing high unmet patient needs.

• 415 CAPITAL — Oberhaching, Bayern, Germany-based venture capital firm investing at Series A round stage in early- and development-stage medical technology companies. The firm focuses on large unmet patient needs in chronic diseases, with emphasis on cardio and neurovascular disorders, aiming to improve patient outcomes and quality of life while reducing long-term healthcare costs.

• Asabys Partners — Barcelona, Catalonia, Spain-based venture capital firm investing at Series A round stage across biotech, medical technology and healthcare innovation. Active in health-tech and biopharma, the firm backs highly innovative and transformative technologies in Spain and abroad, working closely with portfolio companies as partners to build and manage disruptive science-driven healthcare businesses.

• Delta Partners — Leopardstown, Dublin, Ireland-based venture capital firm investing at Series A round stage in early-stage technology companies, including healthcare. Established in 1994 with €230 million under management, the firm has made over 50 investments across information technology, communications and healthcare sectors in Ireland and the United Kingdom.

• EIR Ventures — Stockholm, Stockholms Lan, Sweden-based venture capital firm investing at Series A round stage in life sciences. With a strong Nordic foundation, the team focuses on innovative medicine, new therapies, medical technology and digital health addressing significant unmet medical needs, leveraging deep experience in life science investing and company creation.

• HealthCap — Stockholm, Stockholms Lan, Sweden-based venture capital firm investing at Series A round stage exclusively and globally in life sciences. The firm focuses on diseases with high unmet medical needs and breakthrough therapies that aim to transform medical practice and significantly improve the lives of patients.

• Invivo Capital Partners — Barcelona, Catalonia, Spain-based venture capital firm investing at Series A round stage in early-stage healthcare companies. Led by experienced professionals with scientific, technical and financial expertise, the firm leverages strong strategic relationships within the health ecosystem to analyze, invest in and create value for its portfolio companies.

• Jeito Capital — Paris, Ile-de-France, France-based venture capital firm investing at Series A round stage in medical innovation. The firm operates as a global investment company focused on supporting companies developing innovative healthcare solutions.

• Karolinska — Solna, Stockholms Lan, Sweden-based venture capital firm investing at Series A round stage in medical innovation. The firm focuses on identifying and supporting the creation and growth of companies developing differentiated healthcare products designed to improve patients’ lives while delivering attractive returns.

• Kurma Partners — Paris, Ile-de-France, France-based venture capital management company investing at Series A round stage in healthcare and biotechnology innovation. The firm specializes in financing innovative companies within the healthcare sector, supporting the development of transformative biotech and medical solutions.

Have a great day!

Tzakhi

PS Download our full database of 7,100+ VCs and institutional startup investors, including one year of updates: